tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Emily Bodnar, 224 are a BUY (86.15%), 36 are a HOLD (13.85%).
Analyst Emily Bodnar, carries an average stock price target met ratio of 25.88% that have a potential upside of 53.96% achieved within 58 days. Previously, Emily Bodnar worked at HC WAINWRIGHT.
Emily Bodnar’s has documented 449 price targets and ratings displayed on 28 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ANAB, AnaptysBio at 29-Sep-2025.
Analyst best performing recommendations are on NXTC (NEXTCURE ).
The best stock recommendation documented was for NXTC (NEXTCURE ) at 7/1/2025. The price target of $3 was fulfilled within 13 days with a profit of $2.56 (581.82%) receiving and performance score of 447.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$56
2 years 3 months 9 days ago
(26-Jun-2023)
0/1 (0%)
$27.35 (95.46%)
Hold
$48
$0.45 (0.95%)
$60
2 years 3 months 14 days ago
(21-Jun-2023)
1/3 (33.33%)
$1.41 (3.03%)
85
Hold
$48
$0.45 (0.95%)
$38
2 years 3 months 15 days ago
(20-Jun-2023)
1/2 (50%)
$1.56 (3.36%)
27
Hold
$48
$0.45 (0.95%)
$71
2 years 3 months 15 days ago
(20-Jun-2023)
0/2 (0%)
$1.56 (3.36%)
Buy
$77
$29.45 (61.93%)
$46
2 years 11 months 24 days ago
(11-Oct-2022)
1/2 (50%)
$37 (92.50%)
617
Which stock is Emily Bodnar is most bullish on?
Which stock is Emily Bodnar is most reserved on?
What Year was the first public recommendation made by Emily Bodnar?
